Home About us Contact
|
Home About us Contact | ||
|
|
||
GE Healthcare (ge + healthcare)
Selected AbstractsDiagnostic Accuracy of Handheld Echocardiography for Evaluation of Aortic StenosisECHOCARDIOGRAPHY, Issue 5 2010Arnd Schaefer M.D. Background: Symptomatic severe aortic stenosis is associated with increased mortality and morbidity. Early identification of these patients by echocardiography is crucial. We conducted this study to evaluate a handheld ultrasound device (HCU) in patients with suspected severe aortic stenosis (AS) in comparison to a standard echocardiography device (SE). Methods: A HCU (Vivid I; GE Healthcare) and a SE device (Philips iE 33) were used to evaluate 50 consecutive patients with suspected severe AS. Two consecutive echocardiographic studies were performed by two experienced and blinded examiners using HCU and SE device. AS was graded by mean transaortic pressure, aortic valve area (AVA), and indexed AVA (AVA adjusted for body surface area). Results: Mean difference for mean transaortic gradient, AVA and indexed AVA for the SE and HCU device were 1.28 mmHg (,0.70 to 3.26 mmHg), ,0.02 cm2 (,0.06 to 0.01 cm2), and ,0.01 cm2/m2 (,0.03 to 0.01 cm2/m2), respectively. Discrepancies between both devices were not associated with misinterpretation of the degree of AS. Conclusion: Our study demonstrates that HCU can be used to evaluate patients with suspected AS. (ECHOCARDIOGRAPHY 2010;27:481-486) [source] Amersham radiochemistry to GE Healthcare,JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, Issue 9-10 2007Sean L. Kitson Abstract I was invited by Professor John R. Jones (University of Surrey) to write a paper to celebrate 50 years of the Journal of Labelled Compounds and Radiopharmaceuticals. The aim of this paper is to outline briefly the history of radiochemistry from The Radiochemical Centre at Amersham in the 1940s to the acquisition by General Electric in 2004 and the formation of GE Healthcare. Copyright © 2007 John Wiley & Sons, Ltd. [source] Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleepACTA ANAESTHESIOLOGICA SCANDINAVICA, Issue 2 2008E. HUUPPONEN Background: Dexmedetomidine, a selective ,2 -adrenoceptor agonist, induces a unique, sleep-like state of sedation. The objective of the present work was to study human electroencephalogram (EEG) sleep spindles during dexmedetomidine sedation and compare them with spindles during normal physiological sleep, to test the hypothesis that dexmedetomidine exerts its effects via normal sleep-promoting pathways. Methods: EEG was continuously recorded from a bipolar frontopolar,laterofrontal derivation with Entropy Module (GE Healthcare) during light and deep dexmedetomidine sedation (target-controlled infusions set at 0.5 and 3.2 ng/ml) in 11 healthy subjects, and during physiological sleep in 10 healthy control subjects. Sleep spindles were visually scored and quantitatively analyzed for density, duration, amplitude (band-pass filtering) and frequency content (matching pursuit approach), and compared between the two groups. Results: In visual analysis, EEG activity during dexmedetomidine sedation was similar to physiological stage 2 (S2) sleep with slight to moderate amount of slow-wave activity and abundant sleep spindle activity. In quantitative EEG analyses, sleep spindles were similar during dexmedetomidine sedation and normal sleep. No statistically significant differences were found in spindle density, amplitude or frequency content, but the spindles during dexmedetomidine sedation had longer duration (mean 1.11 s, SD 0.14 s) than spindles in normal sleep (mean 0.88 s, SD 0.14 s; P=0.0014). Conclusions: Analysis of sleep spindles shows that dexmedetomidine produces a state closely resembling physiological S2 sleep in humans, which gives further support to earlier experimental evidence for activation of normal non-rapid eye movement sleep-promoting pathways by this sedative agent. [source] Global oximetry: an international anaesthesia quality improvement projectANAESTHESIA, Issue 10 2009I. A. Walker Summary Pulse oximetry is mandatory during anaesthesia in many countries, a standard endorsed by the World Health Organization ,Safe Surgery Saves Lives' initiative. The Association of Anaesthetists of Great Britain and Ireland, the World Federation of Societies of Anaesthesiologists and GE Healthcare collaborated in a quality improvement project over a 15-month period to investigate pulse oximetry in four pilot sites in Uganda, Vietnam, India and the Philippines, using 84 donated pulse oximeters. A substantial gap in oximeter provision was demonstrated at the start of the project. Formal training was essential for oximeter-naïve practitioners. After introduction of oximeters, logbook data were collected from over 8000 anaesthetics, and responses to desaturation were judged appropriate. Anaesthesia providers believed pulse oximeters were essential for patient safety and defined characteristics of the ideal oximeter for their setting. Robust systems for supply and maintenance of low-cost oximeters are required for sustained uptake of pulse oximetry in low- and middle-income countries. [source] Performance of four carbon dioxide absorbents in experimental and clinical settingsANAESTHESIA, Issue 3 2009M. Yamakage Summary To evaluate the performance of four kinds of carbon dioxide (CO2) absorbents (Medisorb® GE Healthcare, Amsorb® Plus Armstrong Medical, YabashiLime® Yabashi Industries, and Sodasorb® LF Grace Performance Chemicals), we measured their dust production, acceptability of colour indicator, and CO2 absorption capacity in in vitro experimental settings and the concentration of compound A in an inspired anaesthetic circuit during in vivo clinical practice. In vitro, the order of the dust amount was Sodasorb LF > Medisorb > Amsorb Plus = YabashiLime both before and after shaking. The order of the color acceptability was similar: Sodasorb LF > Amsorb Plus = Medisorb > YabashiLime both initially and 16 h after CO2 exhaustion. During exposure to 200 ml.min,1 CO2 in vitro, the period until 1 kg of fresh soda lime allowed inspired CO2 to increase to 0.7 kPa (as a mark of utilisation of the absorbent) was longer with Medisorb (1978 min) than with the other absorbents (1270,1375 min). In vivo, compound A (1.0% inspired sevoflurane) was detected only when using Medisorb. While Medisorb has the best ability to absorb CO2, it alone produces compound A. [source] SCAI, GE healthcare congratulate 2005 awardees, encourage applications for 2006 SCAI/GE healthcare fellows grant programCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Issue 1 2005Article first published online: 12 AUG 200 No abstract is available for this article. [source] | ||||||||||||||||||||||